Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028
Your provider sets the exact amount after evaluating your labs, so it is not a fixed number for everyone
Those with weight loss needs accompanied by metabolic syndrome
(2026) Zhu et al
Dimova, S., Hoet, P
Cagrilintide monotherapy produces about 11.8% reduction at 2.4 mg weekly
US$ 23.43
US$ 24.19
US$ 28.56
US$ 23.32
US$ 24.99
US$ 28.61
US$ 26.99
US$ 28.29
US$ 24.24
US$ 20.65
US$ 21.20
US$ 29.87
US$ 20.85
